Vascular endothelial growth factor is implicated in early invasion in cervical cancer

European Journal of Cancer

Volumn 35, Issue 3, 1999, Pages 485-489

  Kodama, J ^b   Seki, N ^b   Tokumo, K ^b   Hongo, A ^b   Miyagi, Y ^b   Yoshinouchi, M ^a   Okuda, H ^b   Kudo, T ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Angiogenesis; Cervical cancer; Reverse transcription polymerase chain reaction; Vascular endothelial growth factor

Indexed keywords

BETA ACTIN; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MICROCIRCULATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0004011756     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00410-9     Document Type: Article

References (38)

1. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
2. Folkman J. What is the evidence that tumours are angiogenesis-dependent? J. Natl. Cancer Inst. 82:1990;4-6.
3. Liotta L., Kleinerman J., Saldel G. Quantitative relationships of intravascular tumor cells, tumor vessel, and pulmonary metastases following tumour implantation. Cancer Res. 34:1974;997-1004.
4. Ferrara N., Henzel W.L. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851-858.
5. Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secret a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983.
6. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:1992;18-32.
7. Ferrara N., Leung D.W., Cachianes G., Winer J., Henzel W.L. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol. 198:1991;391-405.
8. Houck K.A., Ferrara N., Winer L., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806-1814.
9. Yeo T., Senger D., Dvorak H., Freter L., Yeo K. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem. Biophys. Res. Commun. 3:1991;1568-1575.
10. Tokumo K., Kodama J., Seki N., et al. Different angiogenic pathways in human cervical cancers. Gynecol. Oncol. 68:1998;38-44.
11. Fujita N., Yaegashi N., Ide Y., et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res. 54:1994;3922-3928.
12. Seki A., Kodama J., Miyagi Y., Kamimura S., Yoshinouchi M., Kudo T. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas. Int. J. Cancer. 73:1997;33-37.
13. Kodama J., Hayase R., Okuda H., Yoshinouchi M., Kudo T. Reverse correlation between P-glycoprotein expression and proliferative activity in endometrial adenocarcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol. 59:1995;45-51.
14. Folkman J., Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
15. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8.
16. Fidler I.J., Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
17. Kuwano M., Ushiro S., Ryuto M., et al. Regulation of angiogenesis by growth factors. Gann. Monogr. Cancer Res. 42:1994;113-125.
18. Ishikawa F., Miyazono K., Hellman U., et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial growth factor. Nature. 338:1989;557-562.
19. Guidi A.J., Abu-Jawdeh G., Berse B., et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst. 87:1995;1237-1245.
20. Yoshiji H., Harris S.R., Thorgeirsson U.P. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res. 57:1997;3924-3928.
21. Takahashi Y., Cleary K.R., Mai M., Kitadai Y., Bucana C.D., Ellis L.M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res. 2:1996;1679-1684.
22. Maeda K., Chung Y.S., Ogawa Y., et al. Prognostic value of vascular endothelial growth factor carcinoma. Cancer. 77:1996;858-863.
23. Obermair A., Bancher-Todsca D., Bilgi S., et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89:1997;1212-1216.
24. Asano M., Yukita A., Matsumoto T., et al. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res. 55:1995;5296-5301.
25. Kohno Y., Iwanari O., Kitao M. Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer. 72:1993;2394-2400.
26. Siracka E., Siracky J., Pappova N., Revesz L. Vascularization and radiocurability in cancer of the uterine cervix. A retrospective study. Neoplasma. 29:1982;183-188.
27. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., Angeletti C.A. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet. 340:1992;145-146.
28. Gasparini G., Weidner N., Maluta S., et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. Int. J. Cancer. 55:1993;739-744.
29. Wakui S., Furusato M., Itoh T., et al. Tumor angiogenesis in prostatic carcinoma with and without bone metastasis: a morphometric study. J. Pathol. 168:1992;257-262.
30. Horak E., Leek R., Klenk N., et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer. Lancet. 340:1992;1120-1124.
31. Bremer G.L., Tiebosch A.T.M.G., van der Putten H.W.H.M., Schouten H.J.A., de Haan J., Arends J.W. Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am. J. Obstet. Gynecol. 174:1996;126-131.
32. Dinh T.V., Hannigan E.V., Smith E.R., Hove M.J., Chopra V., To T. Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet. Gynecol. 87:1996;751-754.
33. Wiggins D.L., Granai C.O., Steinhoff M.M., Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol. Oncol. 56:1995;353-356.
34. Schlenger K., Höckel M., Mitze M., et al. Tumor vascularity - a novel prognostic factor in advanced cervical carcinoma. Gynecol. Oncol. 59:1995;57-66.
35. Dellas A., Moch H., Schultheiss E., et al. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. Gynecol. Oncol. 67:1997;27-33.
36. Obermair A., Wanner C., Bilgi S., et al. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am. J. Obstet. Gynecol. 178:1998;314-319.
37. Rutgers J.L., Mattox T.F., Vargas M.P. Angiogenesis in uterine cervical squamous cell carcinoma. Int. J. Gynecol. Pathol. 14:1995;114-118.
38. Kainz C., Speiser P., Wanner C., et al. Prognostic value of tumor microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res. 15:1995;1549-1552.